Welfarism vs. extra-welfarism

Journal of Health Economics
Werner B F BrouwerFrans F H Rutten

Abstract

'Extra-welfarism' has received some attention in health economics, yet there is little consensus on what distinguishes it from more conventional 'welfarist economics'. In this paper, we seek to identify the characteristics of each in order to make a systematic comparison of the ways in which they evaluate alternative social states. The focus, though this is not intended to be exclusive, is on health. Specifically, we highlight four areas in which the two schools differ: (i) the outcomes considered relevant in an evaluation; (ii) the sources of valuation of the relevant outcomes; (iii) the basis of weighting of relevant outcomes and (iv) interpersonal comparisons. We conclude that these differences are substantive.

References

Feb 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·K MifuneW Rawls
Jul 1, 1995·Medical Decision Making : an International Journal of the Society for Medical Decision Making·E Nord
Mar 1, 1995·Social Science & Medicine·A J Culyer
Jan 1, 1993·Neuropsychobiology·H M van Praag
May 1, 1993·Scientific American·A Sen
Sep 18, 1998·JAMA : the Journal of the American Medical Association·R E Hurley
Jan 7, 1997·Journal of Health Economics·H Bleichrodt
Dec 8, 1997·Journal of Health Economics·P Dolan
Jul 22, 1999·Social Science & Medicine·J A Olsen, J Richardson
Oct 16, 1999·Medical Decision Making : an International Journal of the Society for Medical Decision Making·P Dolan
Oct 28, 1999·Journal of Health Economics·M Johannesson
May 29, 2000·Health Policy·A Maynard
Sep 30, 2000·Journal of Health Economics·W B Brouwer, M A Koopmanschap
Feb 21, 2003·Social Science & Medicine·Stephen Birch, Cam Donaldson
Nov 4, 2004·Social Science & Medicine·Gavin Mooney
Feb 5, 2005·Health Economics·Richard Cookson
Jun 10, 2005·Health Economics·Paul Anand
Aug 16, 2005·Health Policy·Werner B F BrouwerMarc A Koopmanschap
Sep 16, 2005·Applied Health Economics and Health Policy·Aki TsuchiyaPaul Dolan
Sep 12, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Werner B F BrouwerFrans F H Rutten
May 1, 2001·Nursing Management·Aki Tsuchiya

❮ Previous
Next ❯

Citations

Mar 4, 2009·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Bengt Liljas
May 17, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Martin J Buxton, James D Chambers
Sep 7, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Peter MakaiAnna P Nieboer
Dec 1, 2010·Journal of Community Genetics·Wolf H RogowskiJörg Schmidtke
Jan 6, 2010·Health Economics, Policy, and Law·Matthew D Adler
Aug 8, 2013·European Journal of Human Genetics : EJHG·Wolf H RogowskiGeorg Marckmann
Jul 6, 2013·Cost Effectiveness and Resource Allocation : C/E·David BishaiDominic Montagu
Jul 14, 2010·International Journal of Environmental Research and Public Health·Paula K LorgellyAndrew H Briggs
Dec 3, 2013·PharmacoEconomics·Ana BobinacWerner B F Brouwer
Dec 3, 2014·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·James Raftery
Aug 3, 2012·Population Health Metrics·Daniel M Hausman
Nov 13, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·David John Mott, Mehdi Najafzadeh
Dec 4, 2012·Journal of Health Economics·Han Bleichrodt, John Quiggin
May 18, 2012·Journal of Health Economics·Jeff Round
Nov 29, 2011·Journal of Health Economics·Davide Dragone, Luca Savorelli
Jun 29, 2010·Journal of Health Economics·Ana BobinacWerner B F Brouwer
Apr 15, 2016·Social Science & Medicine·Anders Herlitz, David Horan
Nov 21, 2008·Social Science & Medicine·Ken J Buckingham, Nancy Joy Devlin
Oct 1, 2008·Journal of Health Economics·Talitha L FeenstraWerner B F Brouwer
Jul 29, 2008·Social Science & Medicine·Joanna CoastPaula Lorgelly
Sep 27, 2014·Autism Research : Official Journal of the International Society for Autism Research·Nalin PayakachatWerner B F Brouwer
Mar 26, 2011·Health Economics·Mike Paulden, Karl Claxton
Dec 15, 2010·Health Economics·Karl ClaxtonAnthony J Culyer
Oct 20, 2012·Health Economics·Ana BobinacWerner B F Brouwer
Jul 7, 2012·Health Economics·Marc FleurbaeyErik Schokkaert
Feb 27, 2013·Health Economics·David Canning
Oct 16, 2015·Health Economics·Hareth Al-JanabiJoanna Coast
Sep 24, 2015·Health Economics·Davide DragoneLuca Savorelli
Jan 28, 2015·Health Economics·Mark PenningtonUNKNOWN EuroVaQ Team
Aug 21, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Carl TillingWerner Brouwer
Dec 18, 2013·Social Science & Medicine·Judit SimonTom Burns
Jul 15, 2015·Social Science & Medicine·Paul Mark MitchellJoanna Coast
Apr 25, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Peter MakaiIsabelle Fabbricotti
Nov 4, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonJames Smeeding
Mar 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P Garrison
Sep 10, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ana BobinacWerner B F Brouwer
Dec 10, 2014·Health Policy·Wolf H Rogowski, Sebastian Schleidgen
Jul 22, 2014·Vaccine·Ramanan LaxminarayanOle F Norheim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.